Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR

  1. Lookup NU author(s)
  2. Professor Alan Calvert
  3. Dr Fathi Azribi
  4. Rebecca Perrett
  5. Professor Ruth Plummer
Author(s)Spicer J, Calvert AH, Vidal L, Azribi F, Perrett RH, Shahidi M, Temple G, Futreal A, de Bono J, Plummer ER
Publication type Article
JournalJournal of Thoracic Oncology
Year2007
Volume2
Issue8
PagesS410-S410
ISSN (print)
ISSN (electronic)
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.